The goal of this study was to assess the efficacy of presepsin as a severity and mortality prognosis marker for sepsis patients compared to other inflammation or infection indicators, such as leucocytes, erythrocyte sedimentation rate (ESR), or C reactive protein (CRP). The gene discussed is CRP; the disease is Sepsis.